Abstract
Background:
Risk prediction algorithms for coronary heart disease (CHD) are recommended for clinical use. However, their predictive ability remains modest and the inclusion of genetic risk may improve their performance.
Methods:
QRISK2 was used to assess CHD risk using conventional risk factors (CRFs). The performance of a 19 single nucleotide polymorphism (SNP) gene score (GS) for CHD including variants identified by genome-wide association study and candidate gene studies (weighted using the results from the CARDIoGRAMplusC4D meta-analysis) was assessed using the second Northwick Park Heart Study (NPHSII) of 2775 healthy UK men (284 cases). To improve the GS, five SNPs with weak evidence of an association with CHD were removed and replaced with seven robustly associated SNPs – giving a 21-SNP GS.
Results:
The weighted 19 SNP GS was associated with lipid traits (p<0.05) and CHD after adjustment for CRFs, (OR=1.31 per standard deviation, p=0.03). Addition of the 19 SNP GS to QRISK2 showed improved discrimination (area under the receiver operator characteristic curve 0.68 vs. 0.70 p=0.02), a positive net reclassification index (0.07, p=0.04) compared to QRISK2 alone and maintained good calibration (p=0.17). The 21-SNP GS was also associated with CHD after adjustment for CRFs (OR=1.39 per standard deviation, 1.42×10−3), but the combined QRISK2 plus GS score was poorly calibrated (p=0.03) and showed no improvement in discrimination (p=0.55) or reclassification (p=0.10) compared to QRISK2 alone.
Conclusions:
The 19-SNP GS is robustly associated with CHD and showed potential clinical utility in the UK population.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: KB was funded by a MRC CASE studentship with Randox Laboratories (1270920) and JC and SEH were supported by the BHF (BHF PG08/008). FD was supported by the UK Medical Research Council (MC_UU_12013/1-9).
Employment or leadership: SEH is the medical director and minority shareholder of the University College London start-up coronary heart disease risk genetic testing company StoreGene, and has received honoraria for speaking at educational meetings with a pharmaceutical sponsor, but has donated all personal payments to various medical charities.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med 2000;343:16–22.10.1056/NEJM200007063430103Search in Google Scholar
2. Stamler J, Dyer AR, Shekelle RB, Neaton J, Stamler R. Relationship of baseline major risk factors to coronary and all-cause mortality, and to longevity: findings from long-term follow-up of Chicago cohorts. Cardiology 1993;82:191–222.10.1159/000175868Search in Google Scholar
3. Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837–47.10.1161/01.CIR.97.18.1837Search in Google Scholar
4. D’Agostino RB, Grundy S, Sullivan LM, Wilson P, Grp CH. Validation of the Framingham Coronary Heart Disease prediction scores – Results of a multiple ethnic groups investigation. J Am Med Assoc 2001;286:180–7.10.1001/jama.286.2.180Search in Google Scholar
5. Simons LA, Simons J, Friedlander Y, McCallum J, Palaniappan L. Risk functions for prediction of cardiovascular disease in elderly Australians: the Dubbo Study. Med J Aust 2003;178:113–6.10.5694/j.1326-5377.2003.tb05100.xSearch in Google Scholar
6. Barzi F, Patel A, Gu D, Sritara P, Lam TH, Rodgers A, et al. Cardiovascular risk prediction tools for populations in Asia. J Epidemiol Community Health 2007;61:115–21.10.1136/jech.2005.044842Search in Google Scholar
7. Hense HW, Schulte H, Lowel H, Assmann G, Keil U. Framingham risk function overestimates risk of coronary heart disease in men and women from Germany – results from the MONICA Augsburg and the PROCAM cohorts. Eur Heart J 2003;24:937–45.10.1016/S0195-668X(03)00081-2Search in Google Scholar
8. Brindle P, Emberson J, Lampe F, Walker M, Whincup P, Fahey T, et al. Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. Br Med J 2003;327:1267.10.1136/bmj.327.7426.1267Search in Google Scholar PubMed PubMed Central
9. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. Br Med J 2007;335:136.10.1136/bmj.39261.471806.55Search in Google Scholar PubMed PubMed Central
10. Lipid Modification: Cardiovascular Risk Assessment and the Modification of Blood Lipids for the Primary and Secondary Prevention of Cardiovascular Disease. National Institute for Health and Clinical Excellence: Guidance. London 2014.Search in Google Scholar
11. Rose G. Strategy of prevention: lessons from cardiovascular disease. Br Med J (Clin Res Ed) 1981;282:1847–51.10.1136/bmj.282.6279.1847Search in Google Scholar PubMed PubMed Central
12. Collins GS, Altman DG. An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study. Br Med J 2010;340:c2442.10.1136/bmj.c2442Search in Google Scholar PubMed PubMed Central
13. Madjid M, Willerson JT. Inflammatory markers in coronary heart disease. Br Med Bull 2011;100:23–38.10.1093/bmb/ldr043Search in Google Scholar PubMed
14. Kamstrup PR, Tybjaerg-Hansen A, Nordestgaard BG. Extreme lipoprotein(a) levels and improved cardiovascular risk prediction. J Am Coll Cardiol 2013;61:1146–56.10.1016/j.jacc.2012.12.023Search in Google Scholar PubMed
15. Joint British Societies’ consensus recommendations for the prevention of cardiovascular disease (JBS3). Heart 2014;100(Suppl 2):ii1–67.10.1136/heartjnl-2014-305693Search in Google Scholar PubMed
16. Deloukas P, Kanoni S, Willenborg C, Farrall M, Assimes TL, Thompson JR, et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet 2013;45:25–U52.10.1038/ng.2480Search in Google Scholar PubMed PubMed Central
17. de Vries PS, Kavousi M, Ligthart S, Uitterlinden AG, Hofman A, Franco OH, et al. Incremental predictive value of 152 single nucleotide polymorphisms in the 10-year risk prediction of incident coronary heart disease: the Rotterdam Study. Int J Epidemiol 2015;44:682–8.10.1093/ije/dyv070Search in Google Scholar PubMed
18. Morris RW, Cooper JA, Shah T, Wong A, Drenos F, Engmann J, et al. Marginal role for 53 common genetic variants in cardiovascular disease prediction. Heart 2016;102:1640.10.1136/heartjnl-2016-309298Search in Google Scholar PubMed PubMed Central
19. Ganna A, Magnusson PK, Pedersen NL, de Faire U, Reilly M, Arnlov J, et al. Multilocus genetic risk scores for coronary heart disease prediction. Atertio Thromb Vasc Biol 2013;33:2267–72.10.1161/ATVBAHA.113.301218Search in Google Scholar PubMed
20. Tada H, Melander O, Louie JZ, Catanese JJ, Rowland CM, Devlin JJ, et al. Risk prediction by genetic risk scores for coronary heart disease is independent of self-reported family history. Eur Heart J 2016;37:561–7.10.1093/eurheartj/ehv462Search in Google Scholar PubMed PubMed Central
21. Humphries SE, Cooper JA, Talmud PJ, Miller GJ. Candidate gene genotypes, along with conventional risk factor assessment, improve estimation of coronary heart disease risk in healthy UK men. Clin Chem 2007;53:8–16.10.1373/clinchem.2006.074591Search in Google Scholar PubMed
22. Talmud PJ, Cooper JA, Palmen J, Lovering R, Drenos F, Hingorani AD, et al. Chromosome 9p21.3 coronary heart disease locus genotype and prospective risk of CHD in healthy middle-aged men. Clin Chem 2008;54:467–74.10.1373/clinchem.2007.095489Search in Google Scholar PubMed
23. Beaney KE, Cooper JA, Ullah Shahid S, Ahmed W, Qamar R, Drenos F, et al. Clinical Utility of a Coronary Heart Disease Risk Prediction Gene Score in UK Healthy Middle Aged Men and in the Pakistani Population. PLoS One 2015;10:e0130754.10.1371/journal.pone.0130754Search in Google Scholar PubMed PubMed Central
24. Bennet AM, Di Angelantonio E, Ye Z, Wensley F, Dahlin A, Ahlbom A, et al. Association of apolipoprotein E genotypes with lipid levels and coronary risk. J Am Med Assoc 2007;298:1300–11.10.1001/jama.298.11.1300Search in Google Scholar PubMed
25. Benn M, Nordestgaard BG, Grande P, Schnohr P, Tybjaerg-Hansen A. PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses. J Am Coll Cardiol 2010;55:2833–42.10.1016/j.jacc.2010.02.044Search in Google Scholar PubMed
26. Miller GJ, Bauer KA, Barzegar S, Foley AJ, Mitchell JP, Cooper JA, et al. The effects of quality and timing of venepuncture on markers of blood coagulation in healthy middle-aged men. Thromb Haemost 1995;73:82–6.10.1055/s-0038-1653729Search in Google Scholar
27. Hawe E, Talmud PJ, Miller GJ, Humphries SE. Family history is a coronary heart disease risk factor in the Second Northwick Park Heart Study. Ann Hum Genet 2003;67(Pt 2):97–106.10.1046/j.1469-1809.2003.00017.xSearch in Google Scholar PubMed
28. Larifla L, Beaney KE, Foucan L, Bangou J, Michel CT, Martino J, et al. Influence of genetic risk factors on coronary heart disease occurrence in afro-caribbeans. Can J Cardiol 2016;32:978–85.10.1016/j.cjca.2016.01.004Search in Google Scholar PubMed PubMed Central
29. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Minhas R, Sheikh A, et al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. Br Med J 2008;336:1475–82.10.1136/bmj.39609.449676.25Search in Google Scholar PubMed PubMed Central
30. Kraft P. Curses – winner’s and otherwise – in genetic epidemiology. Epidemiology 2008;19:649–51; discussion 57–8.10.1097/EDE.0b013e318181b865Search in Google Scholar PubMed
31. Appelman Y, van Rijn BB, Ten Haaf ME, Boersma E, Peters SA. Sex differences in cardiovascular risk factors and disease prevention. Atherosclerosis 2015;241:211–8.10.1016/j.atherosclerosis.2015.01.027Search in Google Scholar PubMed
32. Drenos F. The use of genetic information in the prediction of Type 2 diabetes. Pers Med 2015;12:483–96.10.2217/pme.15.19Search in Google Scholar PubMed
33. National Institute for Health and Care Excellence: Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. London, UK: National Clinical Guideline Centre, 2014.Search in Google Scholar
Supplemental Material:
The online version of this article (DOI: https://doi.org/10.1515/cclm-2016-0984) offers supplementary material, available to authorized users.
©2017 Walter de Gruyter GmbH, Berlin/Boston
